News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article reports that the price target for CalciMedica (CALC) has been decreased by 24.39%, settling at $10.54. No further details were provided regarding the reasons for this adjustment.
Cimpress plc (Nasdaq: CMPR) will host a public Q&A call on Thursday, July 30, 2026, at 8:00 AM ET, following the release of its Q4 FY2026 financial results on Wednesday, July 29, 2026, at 4:05 PM ET. Investors can submit live questions via chat …
Cimpress EVP and CEO of Vista, Florian Baumgartner, exercised 1,026 restricted share units (RSUs) on July 15, 2026, receiving an equivalent number of ordinary shares. Concurrently, 488 ordinary shares were withheld at $98.52 per share to cover tax obligations. The RSUs vest over four …
Cimpress plc (NASDAQ: CMPR) announced it will host a live public question and answer conference call following the release of its fourth-quarter and full-year fiscal 2026 financial results. The earnings release is expected after the market close on Thursday, August 14, 2026, and the …
Cimpress PLC (CMPR) shares rose 4.5% to $103.00, but GuruFocus's GF Value rates the stock as "Modestly Overvalued" at 24.6% above its intrinsic value estimate of $82.69. Despite a strong GF Score of 85/100, driven by high growth and momentum, insiders have sold $4.7 …
Search by ticker symbol or company name and select a result to open its chart.